0001179110-13-012215.txt : 20130726 0001179110-13-012215.hdr.sgml : 20130726 20130726190340 ACCESSION NUMBER: 0001179110-13-012215 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130724 FILED AS OF DATE: 20130726 DATE AS OF CHANGE: 20130726 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: THERAVANCE INC CENTRAL INDEX KEY: 0001080014 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943265960 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 901 GATEWAY BLVD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 6508086000 MAIL ADDRESS: STREET 1: 901 GATEWAY BLVD CITY: S. SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: ADVANCED MEDICINE INC DATE OF NAME CHANGE: 20000302 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Aguiar Michael W CENTRAL INDEX KEY: 0001318005 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30319 FILM NUMBER: 13990742 MAIL ADDRESS: STREET 1: 901 GATEWAY BLVD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 edgar.xml FORM 4 - X0306 4 2013-07-24 0 0001080014 THERAVANCE INC THRX 0001318005 Aguiar Michael W THERAVANCE, INC. 901 GATEWAY BOULEVARD SOUTH SAN FRANCISCO CA 94080 0 1 0 0 Sr VP, Chief Financial Officer Common Stock 2013-07-24 4 A 0 5000 0 A 142916 D On February 7, 2013, the reporting person was granted a performance stock award (PSA) covering 5,000 shares of common stock. The PSA vests over approximately four years of service from the grant date, contingent upon the achievement of one of three possible performance goals. Upon the achievement of one of the performance goals on July 24, 2013, the PSA began vesting. Michael W. Aguiar 2013-07-26